Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients

Keyphrases

• Rhinocerebral mucormycosis 100%
• Amphotericin B 100%
• Amphotericin B Colloidal Dispersion 100%
• High Dose 33%
• Nephrotoxicity 33%
• Illness 33%
• Diabetic Patients 33%
• Patients with Diabetes Mellitus 33%
• Immunocompromised Patients 33%
• Life-threatening 33%
• Best Response 33%
• Mucormycosis 33%
• Antifungal Therapy 33%
• Renal Toxicity 33%
• Fungal Infection 33%
• Surgical Excision 33%
• Serum Creatinine Level 33%
• Prior Treatment 33%
• Clinical Description 33%
• Myelodysplastic Syndrome 33%
• Cholesterol Sulfate 33%
• Zygomycosis 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Mucormycosis 100%
• Amphotericin B 100%
• Nephrotoxicity 40%
• Diabetes Mellitus 20%
• Creatinine 20%
• Mycosis 20%
• Antifungal Therapy 20%
• Cholesterol Sulfate 20%
• Zygomycosis 20%
• Amphotericin B Cholesterol Sulfate 20%
• Myelodysplastic Syndrome 20%
• Diseases 20%

Biochemistry, Genetics and Molecular Biology

• Dispersion 100%
• Creatinine Blood Level 50%
• Sulfate 50%